Patents Assigned to HEPACORE LIMITED
  • Publication number: 20140271868
    Abstract: The present invention relates to a method for the treatment of skeletal dysplasia by administering to a patient a composition comprising a therapeutically effective amount of at least one C-type natriuretic peptide (CNP).
    Type: Application
    Filed: April 17, 2014
    Publication date: September 18, 2014
    Applicant: HEPACORE LIMITED
    Inventors: Myriam Golembo, Avner Yayon